According to the latest report by IMARC Group, titled “Gastrointestinal Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global gastrointestinal therapeutics market size. Gastrointestinal, or GI, disorder refers to medical conditions related to the digestive system. These diseases affect the rectum, colon, small and large intestines, gall bladder, liver, and stomach. GI disorders are characterized by various symptoms, such as bloating, pain, nausea, diarrhea, heartburn, and constipation. Gastrointestinal drugs are prescribed based on endoscopy, blood tests, and imaging tests. There are various GI therapeutics available targeted at providing relief and minimizing gastric acidity. Some of the common therapeutics include prescription and over-the-counter (OTC) drugs, such as Afinitor, Dificid, antacids, laxatives, and Aciphex.
Request Free Sample Report: https://www.imarcgroup.com/gastrointestinal-therapeutics-market/requestsample
The global GI therapeutics market is primarily being driven by the increasing prevalence of GI diseases, such as ulcerative colitis, peptic ulcer diseases, and irritable bowel syndrome. In addition to this, the rising geriatric population, which is more prone to GI ailments, is further supporting the market growth. Moreover, the development of cellular therapies and innovative biosimilars for the treatment of GI disorders is also contributing to the growth of the market. Rising health consciousness amongst consumers, improvements in healthcare infrastructure, and innovations in research and development (R&D) activities are some of the factors driving the GI therapeutics market further toward growth. Looking forward, IMARC Group expects the global gastrointestinal therapeutics market to exhibit moderate growth during 2021-2026.
Breakup by Type:
- Branded
- Generic
Breakup by Route of Administration:
- Oral
- Intravenous
- Others
Breakup by Application:
- Ulcerative Colitis
- Crohn's Disease
- GERD
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Competitive Landscape with Key Player:
- Abbott Laboratories
- AbbVie Inc.
- AstraZeneca Plc
- Bausch Health Companies Inc.
- Bayer Aktiengesellschaft
- GlaxoSmithKline Plc
- Janssen Biotech Inc. (Johnson & Johnson)
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi S.A.
- Takeda Pharmaceuticals
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/gastrointestinal-therapeutics-market